According to a new study presented at the Experimental Biology 2009 meeting in New Orleans, a form of pure genistein reduces the number and duration of hot flashes in peri-and post-menopausal women. The study was conducted by KGK Synergize Inc., and sponsored by DSM Nutritional Products Inc. In the multi-center, randomized, double-blind, placebo-controlled trial, half of the enrolled women were given placebo capsules, and the other half were given capsules of a safe, high-purity, non-plant derived, non-allergenic, patent-protected, proprietary genistein branded as geniVida™ by DSM. Study measurements included daily hot flashes (frequency, duration and intensity), individual-specific safety factors and adverse events. According to the study, women receiving 30mg per day of geniVida experienced 40% fewer hot flashes after eight weeks and 44% fewer after 12 weeks vs. baseline. Further, 88.5% in the geniVida group had a 25% or greater reduction in the duration of daily hot flashes vs. baseline at 12 weeks. The genistein in geniVida, formerly known as BONISTEIN®, is a branded, pure, non-soy genistein from DSM. It is available in both food- and pharmaceutical-grades and is supported by extensive, published safety studies. geniVida™ is available in both crystalline and tablet-grade forms. DSM Nutritional Products Inc., 800-526-0189, www.unlimitednutrition-na.dsm.com

From the May 11, 2009, Prepared Foods E-dition